Delivery Order SPE2DB20D9127-SPE2DB25FPQZ2
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $8,339.18 by the Defense Logistics Agency on July 21, 2025, for the supply of Xtandi 80 mg tablets (60-count units). This delivery order was issued without a set-aside designation and is scheduled for completion by July 22, 2025, with performance taking place at the contractor's Park Ridge facility. The award represents a...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $4,169.59 by the Defense Logistics Agency (DLA) on July 22, 2025. The contract, which carries no set-aside designation, calls for the delivery of 60 tablets of Xtandi 80 mg, an oncology medication used in cancer treatment. This delivery order represents one of many pharmaceutical supply orders issued under DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a $4,311.35 firm fixed-price delivery order from the Defense Logistics Agency (DLA) on July 18, 2025, for 120 capsules of Xtandi 40 mg. The delivery order is not designated as a set-aside contract and carries an ultimate completion date of July 21, 2025. This award represents a single delivery transaction executed under DMS Pharmaceutical Group's larger Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $8,339.18 by the Defense Logistics Agency (DLA) on July 24, 2025, for the supply of Xtandi 80 mg tablets (60-count units). The contract is a firm fixed-price delivery order with an ultimate completion date of July 25, 2025, and carries no set-aside designation. This award was issued under DMS Pharmaceutical Group's larger Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $4,311.35 by the Defense Logistics Agency on July 18, 2025, for the supply of Xtandi 40 mg capsules (120-count). The delivery order carries an ultimate completion date of July 21, 2025, and does not utilize a set-aside designation. This award falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order award from the Defense Logistics Agency (DLA) on July 22, 2025, for 60 tablets of Xtandi 80 mg, a prescription medication commonly used in oncology treatment. The delivery order, valued at $4,169.59 with firm fixed pricing, is expected to be completed by July 23, 2025. This award carries no set-aside designation and represents a direct distribution of...
- This federal contract award was issued by the Medical Supply Chain division of the Defense agency to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $4,311.35 firm fixed-price delivery order is for the supply of 120 capsules of the drug Xtandi 40 mg. The contract has an ultimate completion date of May 13, 2025. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA)...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $12,934.05 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of 120 count bottles of the prescription drug Xtandi 40 mg capsules. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,339.18 firm fixed-price delivery order is for the supply of 120 units of the prescription drug Xtandi 40 mg tablets. The contract has an ultimate completion date of December 16, 2024. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $4,311.35 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 120 units of the drug Xtandi (40 mg capsules) with a period of performance ending on October 24, 2024. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of branded and generic prescription drugs,...
- SPE2DB20D9127Indefinite Delivery Contract
- SPE2DB20D9127-SPE2DB25FPQZ2Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $8,339.18 by the Defense Logistics Agency on July 21, 2025, for the supply of Xtandi 40 mg tablets (120-count units). The contract, which carries no set-aside designation, is scheduled for completion by July 22, 2025, and represents a direct pharmaceutical supply delivery to support Department of Defense healthcare requirements. This award was issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.999 billion master contract vehicle valid through November 2026. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively in federal procurement markets. The company's extensive portfolio with the DLA encompasses delivery orders across multiple therapeutic categories, including oncology treatments, biologics, vaccines, and specialty medications. The underlying IDC structure enables the Defense Logistics Agency to issue firm fixed-price delivery orders for pharmaceutical products supporting medical supply needs of military health facilities worldwide, with DMS Pharmaceutical Group serving as the primary distributor for this comprehensive range of branded and generic prescription drugs and medical consumables.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.3k | 7/21/25 |